FDA Delays Approval Of Protalix/Pfizer Gaucher Drug; Seeks More Data From Late-Stage Trials
FDA may be seeking more safety data before approving of Uplyso, a plant cell-derived enzyme replacement therapy.
FDA may be seeking more safety data before approving of Uplyso, a plant cell-derived enzyme replacement therapy.